Clinical observation of coblation assisted transoral microsurgery for the treatment of oral and oropharygneal malignancy
-
摘要: 目的: 探讨等离子射频(RFC)技术辅助的经口微创手术在口咽及口腔恶性肿瘤治疗中的可行性和有效性。方法: 回顾性分析2008-08-2017-08期间就诊并顺利完成RFC技术辅助经口手术治疗的19例口咽及口腔恶性肿瘤患者的资料,其中包括经病理证实的4例口腔鳞状细胞癌(SCC)(2例舌癌及2例口底癌),11例口咽SCC(5例扁桃体癌,4例软腭癌,1例舌根癌及1例软腭下咽重复癌),4例口咽淋巴造血系统恶性肿瘤(3例扁桃体肿瘤,1例累及扁桃体和舌根)。根据AJCC指南,4例口腔癌的分期分别为T1N0M0 1例、T1N2M0 1例、T2N1M0 1例及T2N2M0 1例;11例口咽癌的临床分期分为T1N0M0 5例、T2N0M0 4例、T2N1M0 1例及T2N2M0 1例。结果: 19例患者中接受同期淋巴结清扫及气管切开术的患者分别为6例及4例,单独RFC经口手术的术中出血量均控制在20 ml以内,手术时间均控制在2 h以内,术后13例患者当天即可恢复经口进食流食,4例气管切开的患者均可顺利拔管;4例淋巴造血系统肿瘤患者术后转诊至血液科进一步诊治,余15例SCC患者中除1例术后出院即失访外,其他14例随访时间6~108个月(中位时间24.5个月),至随访结束未发现局部复发病例及肿瘤相关性死亡病例,仅1例软腭下咽重复癌患者术后5个月对侧下咽及食管再发新生癌伴颈部淋巴结转移,另有1例软腭癌患者术后18个月发现颈部淋巴结转移;另有2例患者分别于术后5个月及12个月时因脑出血及心脏病死亡,Kaplan-Meier曲线计算的3年无瘤生存率及总体生存率分别为75.0%及77.9%;所有患者均未发生与手术相关的吞咽、发声及呼吸功能障碍。结论: RFC技术辅助经口手术治疗口腔及口咽恶性肿瘤疗效明确,多数病例能避免开放入路手术及气管切开术的实施,其优点主要体现在术中出血控制、手术难度降低及手术时间缩短和较快的恢复速度、较低的并发症发生率及较高的功能保留率。Abstract: Objective: To evaluate the feasibility and effectiveness of coblation assisted transoral surgery for the treatment of oral and oropharyngeal malignancy.Method: 19 patients who suffered from oral or oropharyngeal malignant tumors underwent coblation assisted transoral surgery from August 2008 to August 2017 were studied. According to the tumor sites and pathological results, there were four oral squamous cell carcinoma (SCC) (two tongue carcinoma and two mouth floor carcinoma), eleven oropharygneal SCC (five tonsillar carcinoma, four soft palate carcinoma, one tongue base cartinama and one multiple carcinoma invading both soft palatine and hypopharynx), and four lymphatic and hematopoietic malignancies (three tonsillar tumors and one tumor invading both tonsil and tongue base). According to AJCC guideline, the stages of four oral SCC were T1N0M0, T1N2M0, T2N1M0, and T2N2M0 respectively; while the stages of eleven orophygneal SCC were T1N0M0 for 5 patients, T2N0M0 for 4 patients, T2N1M0 for one patient, and T2N2M0 for one patient respectively.Result: Among the 19 patients studied, concurrent neck dissections and tracheotomies were performed in six and four patients respectively. For all the transoral procedures, the blood loss could be controlled within 20 ml, while the operative time were controlled within two hours. 13 patients started oral feeding the day they were operated on. All of the four patients who underwent the tracheotomy could be decannulated successfully after surgery. Four patients diagnosed as lymphatic and hematopoietic malignancies turned to hematology department for further treatments. For the remaining 15 SCC patients, 14 were followed up successfully with one loss to follow-up:the follow up time ranged from 6 to 108 months, during these times, one patient with multiple carcinomas invading the soft palate and hypopharynx had developed new carcinomas located in contralateral hypopharynx and esophagus and had the metastasis in cervical lymph nodes 5 months after surgery, another patient with soft palate carcinoma had the metastasis in cervical lymph nodes 18 months after surgery. Two patients died because of intracranial hemorrhage and cardiovascular event 5 and 12 months after surgery respectively. The three years' tumor free survival and overall survival rates calculated by Kaplan-Meier method were 75.0% and 77.9% respectively. All patients had no severe dysfunctions for swallow, speech and breathing related to the surgery.Conclusion: Radiofrenquency coblation assisted transoral surgery for oral and oropharygneal carcinoma has definite therapeutic effect. Most cases can avoid open surgery and tracheotomy.The advantages are blood control, simplifing surgery,shortening operational time,faster recovery, lower incidence of complications and better preservation of organ function.
-
Key words:
- radiofrequency coblation /
- oral malignancy /
- oropharygneal malignancy /
- microsurgery
-
-
[1] MAK-KREGAR S, HILGERS F J, LEVENDAG P C, et al.A nationwide study of the epidemiology, treatment and survival of oropharyngeal carcinoma in the Netherlands[J].Eur Arch Otorhinolaryngol, 1995, 252:133-138.
[2] 胡尚英, 陈万青, 赵方辉, 等.中国2003-2007年口腔和喉咽癌发病与死亡分析[J].中国流行病杂志, 2013, 34 (2):164-167.
[3] EPSTEIN J B, KISH R V, Hallajian L, et al.Head and neck, oral, and oropharyngeal cancer:a review of medicolegal cases[J].Oral Surg Oral Med Oral Pathol Oral Radiol, 2015, 119:177-186.
[4] MONTERO P H, PATEL S G.Cancer of the oral cavity[J].Surg Oncol Clin N Am, 2015, 24:491-508.
[5] SUMER B D, GOYAL V, TRUELSON J M, et al.Transoral robotic surgery and transoral laser microsurgery for oropharyngeal squamous cell cancer[J].J Robot Surg, 2013, 7:377-383.
[6] 陈伟, 邱德业, 许风雷, 等.经口入路机器人手术在耳鼻咽喉头颈外科中的应用[J].中国耳鼻咽喉颅底外科杂志, 2016, 22 (4):293-297.
[7] SANSONI E R, GROSS N D.The role of transoral robotic surgery in the management of oropharyngeal squamous cell carcinoma:a current review[J].Curr Oncol Rep, 2015, 17:432.
[8] MORTENSEN A, JARDEN M.Early and late physical and psychosocial effects of primary surgery in patients with oral and oropharyngeal cancers:a systematic review[J].Oral Surg Oral Med Oral Pathol Oral Radiol, 2016, 121:583-594.
[9] 肖水芳.射频技术在咽喉头颈外科手术中的应用[J].临床外科杂志, 2016, 30 (11):848-852.
[10] KLOZAR J, LISCHKEOVÁB, BETKA J.Subjective functional results 1year after surgery and postoperative radiation for oropharyngeal carcinoma[J].Eur Arch Otorhinolaryngol, 2001, 258:546-551.
[11] DWIVEDI R C, KAZI R A, AGRAWAL N, et al.Evaluation of speech outcomes following treatment of oral and oropharyngeal cancers[J].Cancer Treat Rev, 2009, 35:417-424.
[12] CARNEY A S, TIMMS M S, MARNANE C N, et al.Radiofrequency coblation for the resection of head and neck malignancies[J].Otolaryngol Head Neck Surg, 2008, 138:81-85.
[13] 李五一, 霍红, 杨大勇, 等.离子射频辅助经口内镜微创切除浅表舌根肿瘤[J].中华耳鼻咽喉头颈外科杂志, 2017, 52 (5):332-336.
[14] 肖水芳, 李五一, 张俊波, 等.等离子射频辅助经口手术治疗下咽癌[J].中华耳鼻喉咽喉头颈外科杂志, 2017, 52 (5):325-331.
-
计量
- 文章访问数: 203
- PDF下载数: 953
- 施引文献: 0